A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2011
03/29/2011	US7915223 Antimicrobial agents
03/29/2011	US7915222 Method of preventing the development of rheumatoid arthritis in subjects with undifferentiated arthritis
03/29/2011	US7915221 Methods for construction and screening of libraries of chemokine variants
03/29/2011	US7915220 dextrorotatory amino acids; vGek with Dval-gly-Dglu-Dlys as a central D-amino acid sequence; protect against amyloid-mediated neurotoxicity; have no similarities to the amino acid sequence in beta -amyloid regardless of the direction in which they are read
03/29/2011	US7915219 treatment of cell damage caused by ischemia or stroke by administering to a cell or a tissue an effective amount of an isozyme specific delta PKC (protein kinase C) antagonist
03/29/2011	US7915040 Defensin-antigen fusion proteins
03/29/2011	US7915025 In vivo incorporation of unnatural amino acids
03/29/2011	US7915024 Feed containing bacillus keratinase; efficient utilization
03/29/2011	US7915009 Modulating NF-kappa B by administering antigens or polynucleotide encoding antigens, antibody; treating cancer, tumor, Alzheimer's disease or a spongiform encephalopathy; DNA vaccine in kits
03/29/2011	US7915001 Detection of specific nitrated markers
03/29/2011	US7914819 Polysaccharide-based biomaterials
03/29/2011	US7914816 Endoparasiticidal agents for voluntary oral ingestion by animals
03/29/2011	US7914789 HEMCM42 antibodies
03/29/2011	US7914787 Provide inter alia a bi-specific antibody or antibody fragment having one arm that specifically binds a targeted tissue and one other arm that specifically binds a targetable conjugate that can be modified for use in a wide variety of diagnostic and therapeutic applications
03/29/2011	US7914783 Liquefying a vitreous and/or inducing posterior vitreous detachment of an eye via microplasmin injection; treating vision defects
03/29/2011	US7914782 Enzymes for reduced immunological stress
03/29/2011	US7914781 Compositions for inhibiting atherosclerosis
03/29/2011	US7914780 Aminopeptidase A (APA) targeting peptides for the treatment of cancer
03/29/2011	US7914778 Methods of treatment using IL-16 antagonist peptides
03/29/2011	US7914774 Skin care composition for accelerated production of collagen proteins and method of fabricating the same
03/29/2011	US7914771 Treatment of chronic obstructive pulmonary disease by low dose inhalation of protease inhibitor
03/29/2011	US7914537 Devices and methods for the restoration of a spinal disc
03/29/2011	CA2617341C Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus
03/29/2011	CA2463544C Cross-linked glycopeptide-cephalosporin antibiotics
03/29/2011	CA2463521C Antisense modulation of insulin-like growth factor binding protein 5 expression
03/29/2011	CA2447040C Assays, methods and means
03/29/2011	CA2446327C A polypeptide and dna thereof useful as a neovascular marker
03/29/2011	CA2435146C Formulation of boronic acid compounds
03/29/2011	CA2418784C Use of compounds derived from the genus euphorbia for the treatment of carcinoma of the bladder
03/29/2011	CA2412750C Substituted metal-phthalocyanines, their preparation and the use thereof
03/29/2011	CA2410968C Method of treating chronic ulcers
03/29/2011	CA2397016C Use of lipid conjugates in the treatment of disease
03/29/2011	CA2390652C Human circulating virus-inhibiting peptide (virip) and its use
03/29/2011	CA2381992C Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
03/29/2011	CA2345276C Flt4 (vegfr-3) as a target for tumor imaging and anti-tumor therapy
03/29/2011	CA2344974C Chimaeric proteins between members of tgf-beta superfamily
03/29/2011	CA2331071C A colostrum food composition and method of using same
03/29/2011	CA2263798C G-coupled receptor showing selective affinity for atp
03/29/2011	CA2256306C Antibodies against a complex of cd4 and a chemokine receptor domain, and their use against hiv infections
03/29/2011	CA2252438C Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability
03/29/2011	CA2239151C Integrin-linked kinase, its inhibitors and methods of medical treatment using these inhibitors, gene therapy and pseudo-substrate inhibitors
03/29/2011	CA2207815C Modulators of the function of fas/apo1 receptors
03/29/2011	CA2165573C Anti-.alpha.v-integrin monoclonal antibody
03/24/2011	WO2011035330A2 Oxytocin receptor agonists
03/24/2011	WO2011035128A1 Method of treating asthma with antiviral agents
03/24/2011	WO2011035108A1 Formulations of daptomycin
03/24/2011	WO2011035079A1 Pancreatic enzyme compositions and methods for treating pancreatitis and pancreatic insufficiency
03/24/2011	WO2011035018A2 Suicide ready cells
03/24/2011	WO2011035013A2 Implant devices that differ by release profile and methods of making and using same
03/24/2011	WO2011034976A1 Fluorinated ghrh antagonists
03/24/2011	WO2011034951A2 Assisted enzyme replacement therapy
03/24/2011	WO2011034919A2 Sh2 domain profiling to characterize tyrosine phosphorylation signaling in cancer
03/24/2011	WO2011034659A2 Advantageous mu-opiate receptor peptide compounds
03/24/2011	WO2011034583A2 Inhibition of endosomal toll-like receptor activation
03/24/2011	WO2011034580A2 Small peptide modulators of potassium channel trafficking
03/24/2011	WO2011034464A1 Injectable dosage form for the treatment of an acute ischaemic insult and cranial trauma, manufacturing method and use
03/24/2011	WO2011034207A1 Partial peptide of lacritin
03/24/2011	WO2011034131A1 Agent for the prevention or treatment of inflammatory bowel disease
03/24/2011	WO2011034105A1 Modified erythropoietin to which water-soluble long-chain molecule is added
03/24/2011	WO2011033511A1 Peptides for the treatment of oxidative stress related disorders
03/24/2011	WO2011033391A2 Methods of treating a patient receiving a cardiac stent implant
03/24/2011	WO2011033358A2 Novel peptides isolated from spider venom, and uses thereof
03/24/2011	WO2011033068A1 Long-acting y2 receptor agonists
03/24/2011	WO2011033019A1 Stable non-aqueous liquid pharmaceutical compositions comprising an insulin
03/24/2011	WO2011032981A1 Use of arc for inhibiting cell death during liver failure
03/24/2011	WO2011032360A1 Momordica charantia peptide mc-jj2 and microwave promoted solid phase synthesis method thereof
03/24/2011	WO2011032359A1 Momordica charantia peptide mc-jj6 and microwave promoted solid phase synthesis method thereof
03/24/2011	WO2011032233A1 Novel omega conotoxin peptides
03/24/2011	WO2011032195A1 Medicinal products for the treatment of blood coagulation disorders containing thrombin-free factor xia concentrate
03/24/2011	WO2011012306A3 Use of emps for antagonising epo-stimulatory effects on epo-responsive tumors while maintaining erythropoiesis
03/24/2011	WO2011011071A3 Analogues of insulin-like growth factor-1 (igf-1)
03/24/2011	WO2011008260A3 Bifunctional stapled polypeptides and uses thereof
03/24/2011	WO2010148007A9 Nanoparticle and polymer formulations for thyroid hormone, analogs, antagonists, and formulations and uses thereof
03/24/2011	WO2010137021A3 Method of generating connective tissue
03/24/2011	WO2010129406A3 Methods of promoting muscle growth
03/24/2011	WO2010128524A3 Combined measles-malaria vaccine
03/24/2011	WO2010127209A3 Compositions and methods for therapy of macular degeneration
03/24/2011	WO2010111653A3 Modulating ires-mediated translation
03/24/2011	WO2010111516A3 Compositions and methods for inhibiting biofilms
03/24/2011	WO2010108001A3 Agents and methods for tissue repair and regeneration
03/24/2011	WO2010102052A3 Methods of inhibiting photoreceptor apoptosis
03/24/2011	WO2010096394A3 Aldehyde-tagged protein-based drug carriers and methods of use
03/24/2011	WO2010096385A3 Methods and compositions for the treatment of autoimmune disease
03/24/2011	WO2010094031A8 Recombinant human follicle stimulating hormone antagonists and methods of use thereof
03/24/2011	WO2010091381A3 An intermittent dosing strategy for treating rheumatoid arthrtis
03/24/2011	WO2010058227A3 NOVEL USES OF VEGFxxxB
03/24/2011	WO2008116468A8 Mhc peptide complexes and uses thereof in infectious diseases
03/24/2011	US20110072524 Transgenic Mouse Lacking Endogenous FVIII and VWF - A Model of Hemophilia A
03/24/2011	US20110071612 Anti-angiogenic compositions and methods of use
03/24/2011	US20110071499 Free-standing biodegradable patch
03/24/2011	US20110071498 Free-standing biodegradable patch
03/24/2011	US20110071285 Low-molecular serine proteases inhibitors comprising polyhydroxy-alkyl and polyhydroxy-cycloalkyl radicals
03/24/2011	US20110071213 Card-domain containing polypeptides, encoding nucleic acids, and methods of use
03/24/2011	US20110071212 P185neu-encoding dna and therapeutical uses thereof
03/24/2011	US20110071102 Compositions and Methods to Treat Recurrent Medical Conditions
03/24/2011	US20110071093 Novel Reagents
03/24/2011	US20110071092 Anti-inflammatory compounds and uses thereof
03/24/2011	US20110071091 Injectable aqueous ophthalmic composition and method of use therefor
03/24/2011	US20110071090 Method of mitigating adverse drug events using omega-3-fatty acids as a parenteral therapeutic drug vehicle
03/24/2011	US20110071089 Peptide composition for cancer treatment by inhibiting trpv6 calcium channel activity

1 ... 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 ... 3163